The central neuropharmcology of psychotropic cannabinoids
- 1 January 1988
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 36 (2-3) , 189-261
- https://doi.org/10.1016/0163-7258(88)90106-4
Abstract
No abstract availableThis publication has 193 references indexed in Scilit:
- Prostaglandins and cannabis XV. Comparison of enantiomeric cannabinoids in stimulating prostaglandin synthesis in fibroblastsLife Sciences, 1986
- Cannabinoids And The Cholinergic SystemThe Journal of Clinical Pharmacology, 1981
- Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral AdministrationThe Journal of Clinical Pharmacology, 1981
- Electrophysiologic Properties of the CannabinoidsThe Journal of Clinical Pharmacology, 1981
- Behavioral Effects of Levonantradol and Nantradol in the Rhesus MonkeyThe Journal of Clinical Pharmacology, 1981
- Levonantradol‐Induced Inhibition of Acetylcholine Turnover in Rat Hippocampus and StriatumThe Journal of Clinical Pharmacology, 1981
- Behavioral comparisons of the stereoisomers of tetrahydrocannabinolsLife Sciences, 1981
- Inhibition of cholesterol esterases by Δ1-tetrahydrocannabinolLife Sciences, 1978
- Effects of Δ9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomesLife Sciences, 1976
- Stabilization of rat erythrocyte membrane by △1-tetrahydrocannabinolLife Sciences, 1971